STOCKHOLM, Sweden, Oct. 7, 2005 (PRIMEZONE) -- The following people have been appointed as members of Vitrolife's election committee for the Annual General Meeting in 2006:
Henrik Blomquist, representing Skanditek Industriforvaltning Carl Rosen, representing Andra AP-fonden (Second National Pension Insurance Fund) Gunnar Lindberg, representing Lansforsakringars Smabolagsfond Patrik Tigerschiold, Chairman of the Board
The appointments have been made in accordance with the instructions regarding principles for the appointment of the company election committee, which were determined at the Annual General Meeting of Vitrolife on May 10, 2005.
October 7, 2005 Kungsbacka, Sweden
Vitrolife AB (publ)
Vitrolife is a global biotechnology/medical device Group that works with developing, manufacturing and selling advanced products and systems for the preparation, cultivation and storage of human cells, tissue and organs. The company has business activities within three product areas: Fertility, Transplantation and Cell therapy. The Fertility product area works with nutrient solutions (media) for the treatment of human infertility. The Transplantation product area works with solutions and systems to maintain tissue in optimal condition outside the body for the required time while waiting for transplantation. The Cell therapy product area works with media to enable the use of stem cells for therapeutic purposes.
Vitrolife today has over 80 employees and the company's products are sold in more than 80 markets. The head office is in Kungsbacka, Sweden, and there is a subsidiary in Denver, USA. The Vitrolife share is listed on the O-list of the Stockholm Stock Exchange.
Vitrolife AB (publ), Faktorvagen 13, SE-434 37 Kungsbacka, Sweden. Corporate identity number 556354-3452. Tel: +46 31 721 80 00. Fax: +46 31 721 80 90. E-mail: info@vitrolife.com. Homepage: www.vitrolife.com.
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download:
http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=138084&fn=wkr0001.pdf